Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that ...
Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational medication mezagitamab can effectively boost platelet ...
A 47-year-old woman in Germany had spent more than a decade battling three severe autoimmune diseases at once: autoimmune ...
Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that the investigational ...
IFLScience on MSN
CAR-T therapy is revolutionizing cancer treatment. Next on the list: autoimmune disease
A woman who had been sick for many years with three autoimmune conditions has experienced a remarkable recovery after being ...
Cell therapy helps woman with three deadly autoimmune diseases make ‘remarkable’ recovery - Researchers say this type of cell therapy could help more patients with severe autoimmune disease ...
For the first time, scientists have used a cutting-edge cell therapy called CAR-T to treat a patient with three different ...
The Japanese pharma is currently investigating mezagitamab’s potential in two late-stage autoimmune programmes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results